Tayanes, Zayden R.
HRN: 27-01-90 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/26/2025
06/02/2025
IV
67mg
OD
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes